Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination.
about
HPV vaccine: Current status and future directionsAnalysis of longitudinal multivariate outcome data from couples cohort studies: application to HPV transmission dynamics.Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV typesHPV catch-up vaccination of young women: a systematic review and meta-analysis.Evaluation of human papillomavirus type replacement postvaccination must account for diagnostic artifacts: masking of HPV52 by HPV16 in anogenital specimensInvited commentary: multiple human papillomavirus infections and type replacement-anticipating the future after human papillomavirus vaccination.Post hoc analysis of the PATRICIA randomized trial of the efficacy of human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against incident and persistent infection with nonvaccine oncogenic HPV types using an alternative multiplex tPapillomaviruses: Viral evolution, cancer and evolutionary medicineEpidemiologic Evaluation of Human Papillomavirus Type Competition and the Potential for Type Replacement Post-VaccinationDeep sequencing of HPV E6/E7 genes reveals loss of genotypic diversity and gain of clonal dominance in high-grade intraepithelial lesions of the cervix.Shift in prevalence of HPV types in cervical cytology specimens in the era of HPV vaccinationPopulation-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes.Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays.Dynamics of high-risk nonvaccine human papillomavirus types after actual vaccination scheme.The road ahead for cervical cancer prevention and control.The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon.Human papillomavirus vaccines: key factors in planning cost-effective vaccination programs.Cervical cancer screening in the era of HPV vaccination: A review of shifting paradigms in cytopathology.Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials.Bias Due to Correlation Between Times-at-Risk for Infection in Epidemiologic Studies Measuring Biological Interactions Between Sexually Transmitted Infections: A Case Study Using Human Papillomavirus Type Interactions.Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007.Multiple high-risk HPV genotypes are grouped by type and are associated with viral load and risk factors.Cervical Infection With Vaccine-Associated Human Papillomavirus (HPV) Genotypes as a Predictor of Acquisition and Clearance of Other HPV Infections.Multiple human papillomavirus infection with or without type 16 and risk of cervical intraepithelial neoplasia among women with cervical cytological abnormalities.Human papillomavirus detection using the Abbott RealTime high-risk HPV tests compared with conventional nested PCR coupled to high-throughput sequencing of amplification products in cervical smear specimens from a Gabonese female population.Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy.Determining the HPV vaccine schedule for a HIV-infected population in sub Saharan Africa, a commentaryHuman Papillomavirus Vaccination: Making Sense of the Public ControversyTrends in Biosensors for HPV: Identification and Diagnosis
P2860
Q27026524-99D0C84D-E5F2-4EBB-9510-3AD5E94077ACQ30981780-461D9A8D-078B-4F8C-A510-18DD5694A388Q33682928-D8001E42-EC1D-4028-B32A-8C5FB7564CEEQ34157209-2D89B76A-E440-4E0C-967A-630E7991703DQ34964786-52769FE9-C8A7-4AB8-886A-9EF17006D7CAQ34974475-7C6CABD8-3301-4905-B65E-3D927F5C7D05Q35021139-A6F9B057-2FD3-41BA-8CD1-42105F046526Q35166924-12E4F4FD-4EE3-4BE9-8609-EA79F8EEDDA4Q36231336-98A55477-644B-4BC5-AFD5-04AFF035FBEAQ36306538-04DB3432-4993-4D5E-886E-19E7CAD1CFA1Q37002753-AFE4534B-52DF-4D53-AD0A-E95E90307615Q37288157-97AB0C7B-BC7D-4C87-9BAF-DB77C8486B15Q37363392-904CF2C8-67BD-42AB-B7D3-6D0F81B6AEF6Q37718767-746A1443-C747-4EDE-8FE6-BB74D4445D0CQ37719631-586F89D0-D4D1-4801-9A49-7DF5AB2A4FF6Q38254337-C37873F7-A24F-45E2-9DBD-2FADE49B14AEQ38255277-266D7F28-2D76-4856-AEA2-2CA8B1C846FFQ38673879-D2363BB0-34CA-4C3A-BECF-C5C2BDB635ABQ38993490-DC6357EA-C670-4146-A632-D33E76ADE66FQ39122093-B573DAA8-32FD-4A9D-A3E0-807B0263148AQ39281387-9ABC32E0-05FE-4D1C-B5AA-1CA7CE151359Q40337821-883280BA-50C0-43AA-ACDD-96EC6639B1F9Q40647908-3C972F18-9694-4B23-B33A-63857B906846Q41710612-F9E7A07F-57B0-4AC0-BB22-7447AF91BDB7Q47159754-959F47C7-E00C-4E7A-BBD0-D4B4E28710DCQ49165143-64A7CEF0-7729-492D-B32D-394D0A3B7F4CQ56987144-B51FDE6B-CDFA-46DF-8313-7E44443823AFQ57089326-130C4121-3DBC-4CDF-AB87-55E7203B9F18Q59114620-485C7FA7-85EB-4DD5-AF87-6D539157F9D3
P2860
Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epidemiologic approaches to ev ...... e replacement postvaccination.
@en
Epidemiologic approaches to ev ...... e replacement postvaccination.
@nl
type
label
Epidemiologic approaches to ev ...... e replacement postvaccination.
@en
Epidemiologic approaches to ev ...... e replacement postvaccination.
@nl
prefLabel
Epidemiologic approaches to ev ...... e replacement postvaccination.
@en
Epidemiologic approaches to ev ...... e replacement postvaccination.
@nl
P2093
P2860
P50
P356
P1476
Epidemiologic approaches to ev ...... e replacement postvaccination.
@en
P2093
Agnihotram V Ramanakumar
François Coutlée
Joseph E Tota
Luisa L Villa
Mengzhu Jiang
Stephen D Walter
P2860
P304
P356
10.1093/AJE/KWT018
P407
P577
2013-05-09T00:00:00Z